Diplomat Pharmacy, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 1,287.624 million compared to USD 1,416.078 million a year ago. Operating loss was USD 148.959 million compared to operating Income of USD 7.774 million a year ago. Net loss was USD 159.462 million compared to USD 3.964 million a year ago. Basic loss per share was USD 2.13 compared to USD 0.05 a year ago. For the half year, sales was USD 2,544.432 million compared to USD 2,758.562 million a year ago. Operating loss was USD 152.607 million compared to operating Income of USD 16.465 million a year ago. Net loss was USD 173.763 million compared to USD 4.414 million a year ago. Basic loss per share was USD 2.33 compared to USD 0.06 a year ago.